Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid

Cited 1 time in webofscience Cited 0 time in scopus
  • Hit : 55
  • Download : 0
More than 30 human degenerative diseases result from protein aggregation such as Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM). Islet amyloid deposits, a hallmark in T2DM, are found in pancreatic islets of more than 90% of T2DM patients. An association between amylin aggregation and reduction in beta-cell mass was also established by post-mortem studies. A strategy in preventing protein aggregation-related disorders is to inhibit the protein aggregation and associated toxicity. In this study, we demonstrated that two inhibitors, lipoic acid and ascorbic acid, significantly inhibited amylin aggregation. Compared to amylin (15 mu M) as 100%, lipoic acid and ascorbic acid reduced amylin fibril formation to 42.1 +/- 17.2% and 42.9 +/- 12.8%, respectively, which is confirmed by fluorescence and TEM images. In cell viability tests, both inhibitors protected RIN-m5f beta-cells from the toxicity of amylin aggregates. At 10:1 molar ratio of lipoic acid to amylin, lipoic acid with amylin increased the cell viability to 70.3%, whereas only 42.8% RIN-m5f beta-cells survived in amylin aggregates. For ascorbic acid, an equimolar ratio achieved the highest cell viability of 63.3% as compared to 42.8% with amylin aggregates only. Docking results showed that lipoic acid and ascorbic acid physically interact with amylin amyloidogenic region (residues Ser20-Ser29) via hydrophobic interactions; hence reducing aggregation levels. Therefore, lipoic acid and ascorbic acid prevented amylin aggregation via hydrophobic interactions, which resulted in the prevention of cell toxicity in vitro.
Publisher
AMER CHEMICAL SOC
Issue Date
2018-06
Language
English
Article Type
Article
Keywords

ISLET AMYLOID POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; PROTEIN AGGREGATION; S20G MUTATION; GENE S20G; DISEASES; JAPANESE; FIBRILS; PEPTIDE; PH

Citation

MOLECULAR PHARMACEUTICS, v.15, no.6, pp.2098 - 2106

ISSN
1543-8384
DOI
10.1021/acs.molpharmaceut.7b01009
URI
http://hdl.handle.net/10203/243696
Appears in Collection
BiS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 1 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0